Pulmonary hypertension in bronchopulmonary dysplasia

被引:26
作者
Mourani, Peter M. [1 ,2 ,3 ]
Mullen, Mary [4 ,5 ]
Abman, Steven H. [1 ,2 ,3 ]
机构
[1] Univ Colorado Denver, Pediat Heart Lung Ctr, Sch Med, Dept Pediat,Sect Crit Care Med, Aurora, CO USA
[2] Childrens Hosp, Aurora, CO USA
[3] Univ Colorado Denver, Pediat Heart Lung Ctr, Sch Med, Dept Pediat,Sect Pulm Med, Aurora, CO USA
[4] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA 02115 USA
[5] Childrens Hosp Boston, Boston, MA USA
关键词
Bronchopulmonary dysplasia; Prematurity; Pulmonary hypertension; Inhaled nitric oxide; Angiogenesis; Sildenafil; Endothelin; Endothelin-receptor antagonists; Prostacyclin;
D O I
10.1016/j.ppedcard.2009.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bronchopulmonary dysplasia (BPD), the chronic lung disease that follows oxygen and ventilator therapy of premature neonates, is characterized by significant cardiac and pulmonary sequelae. Since its original description in the late '60s, poor outcome in BPD has been strongly associated with late pulmonary hypertension (PH). Despite progressive improvements in the care of preterm infants, PH still remains a significant cause of late morbidity and mortality in premature infants. More recently, experimental and clinical studies have shown that lung vascular growth is abnormal in infants with BPD, which may contribute to abnormalities of lung airspace structure, alters gas exchange with respiratory infections and exercise, and further increases the risk for developing PH. Current data are limited with regards to many fundamental aspects of pulmonary vascular disease and PH in infants with BPD, including: basic mechanisms that alter lung vascular growth and development after premature birth and may contribute to the pathogenesis of PH; the prevalence and natural history of PH in infants with BPD; approaches to screen and diagnose PH in this group; and effective therapies for the prevention and treatment of PH in infants with BPD. This article discusses recent observations and recommendations in the clinical approach to PH in BPD and highlights current gaps in our knowledge. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 50 条
[21]   Can microsomal RNA be a biomarker in pulmonary hypertension secondary to bronchopulmonary dysplasia? [J].
Guler, Esra ;
Narin, Nazmi ;
Pamukcu, Ozge ;
Taheri, Serpil ;
Tufan, Esra ;
Guler, Yunus ;
Tunca, Aydin ;
Baykan, Ali .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (09) :1401-1406
[22]   Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension [J].
Dillon, Kacie ;
Lamba, Vineet ;
Philip, Ranjit R. ;
Weems, Mark F. ;
Talati, Ajay J. .
CHILDREN-BASEL, 2023, 10 (08)
[23]   Pulmonary Hypertension in Bronchopulmonary Dysplasia: Clinical Findings, Cardiovascular Anomalies and Outcomes [J].
Jesus del Cerro, Maria ;
Sabate Rotes, Anna ;
Carton, Antonio ;
Deiros, Lucia ;
Bret, Montserrat ;
Cordeiro, Malaika ;
Verdu, Cristina ;
Isabel Barrios, Maria ;
Albajara, Luis ;
Gutierrez-Larraya, Federico .
PEDIATRIC PULMONOLOGY, 2014, 49 (01) :49-59
[24]   Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia [J].
Varghese, Nidhy P. ;
Altit, Gabriel ;
Gubichuk, Megan M. ;
Siddaiah, Roopa .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)
[25]   Bronchopulmonary dysplasia - associated pulmonary hypertension: An updated review [J].
El-Saie, Ahmed ;
Varghese, Nidhy P. ;
Webb, Melissa K. ;
Villafranco, Natalie ;
Gandhi, Bheru ;
Guaman, Milenka Cuevas ;
Shivanna, Binoy .
SEMINARS IN PERINATOLOGY, 2023, 47 (06)
[26]   Pulmonary hypertension with bronchopulmonary dysplasia: Aichi cohort study [J].
Kawai, Yuri ;
Hayakawa, Masahiro ;
Tanaka, Taihei ;
Yamada, Yasumasa ;
Nakayama, Atsushi ;
Kato, Yuichi ;
Kouwaki, Masanori ;
Kato, Takenori ;
Tanaka, Ryo ;
Muramatsu, Kanji ;
Hayashi, Seiji ;
Yamamoto, Hikaru ;
Takemoto, Koji ;
Ieda, Kuniko ;
Nagaya, Yoshiaki ;
Honda, Shigeru ;
Shinohara, Osamu ;
Funato, Yusuke ;
Kokubo, Minoru ;
Imamine, Hiroki ;
Miyata, Masafumi .
PEDIATRICS INTERNATIONAL, 2022, 64 (01)
[27]   Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia [J].
Levy, Philip T. ;
Levin, Jonathan ;
Leeman, Kristen T. ;
Mullen, Mary P. ;
Hansmann, Georg ;
Kourembanas, Stella .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2022, 27 (04)
[28]   Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia [J].
Sullivan, Rachel T. T. ;
Tandel, Megha D. D. ;
Bhombal, Shazia ;
Adamson, Gregory T. T. ;
Boothroyd, Derek B. B. ;
Tracy, Michael ;
Moy, Amanda ;
Hopper, Rachel K. K. .
FRONTIERS IN PEDIATRICS, 2022, 10
[29]   Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature [J].
Altit, Gabriel ;
Dancea, Adrian ;
Renaud, Claudia ;
Perreault, Therese ;
Lands, Larry C. ;
Sant'Anna, Guilherme .
PAEDIATRIC RESPIRATORY REVIEWS, 2017, 23 :16-26
[30]   Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension [J].
Gentle, Samuel J. ;
Travers, Colm P. ;
Clark, Matthew ;
Carlo, Waldemar A. ;
Ambalavanan, Namasivayam .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (07) :921-928